REXAHN PHARMACEUTICALS INC's ticker is RNN and the CUSIP is 761640101. A total of 36 filers reported holding REXAHN PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $30,000 | -16.7% | 145,000 | 0.0% | 0.01% | -22.2% |
Q2 2016 | $36,000 | -25.0% | 145,000 | 0.0% | 0.01% | -25.0% |
Q1 2016 | $48,000 | -56.4% | 145,000 | -31.4% | 0.01% | -58.6% |
Q3 2015 | $110,000 | -14.1% | 211,371 | 0.0% | 0.03% | -6.5% |
Q2 2015 | $128,000 | -16.9% | 211,371 | 0.0% | 0.03% | -16.2% |
Q1 2015 | $154,000 | +81.2% | 211,371 | +74.2% | 0.04% | +60.9% |
Q4 2014 | $85,000 | -41.4% | 121,324 | -32.1% | 0.02% | -42.5% |
Q3 2014 | $145,000 | +45.0% | 178,691 | +55.4% | 0.04% | +42.9% |
Q2 2014 | $100,000 | – | 114,987 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Northeast Financial Consultants Inc | 150,000 | $109,000 | 0.05% |
CONDOR CAPITAL MANAGEMENT | 211,371 | $154,000 | 0.04% |
Benin Management CORP | 83,000 | $61,000 | 0.03% |
First Heartland Consultants, Inc. | 20,000 | $15,000 | 0.01% |
Advisory Services Network, LLC | 22,000 | $16,000 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 180,000 | $131,000 | 0.00% |
Moors & Cabot, Inc. | 11,000 | $7,000 | 0.00% |
TCI Wealth Advisors, Inc. | 3,000 | $2,000 | 0.00% |
Corbenic Partners LLC | 1,600 | $1,000 | 0.00% |
WFG Advisors, LP | 3,500 | $3,000 | 0.00% |